Human gyrovirus DNA in human blood, Italy

Pisa University Hospital, Pisa, Italy.
Emerging Infectious Diseases (Impact Factor: 7.33). 06/2012; 18(6):956-9. DOI: 10.3201/eid1806.120179
Source: PubMed

ABSTRACT Human gyrovirus (HGyV) is a recent addition to the list of agents found in humans. Prevalence, biologic properties, and clinical associations of this novel virus are still incompletely understood. We used qualitative PCRs to detect HGyV in blood samples of 301 persons from Italy. HGyV genome was detected in 3 of 100 solid organ transplant recipients and in 1 HIV-infected person. The virus was not detected in plasma samples from healthy persons. Furthermore, during observation, persons for whom longitudinal plasma samples were obtained had transient and scattered presence of circulating HGyV. Sequencing of a 138-bp fragment showed nucleotide identity among all the HGyV isolates. These results show that HGyV can be present in the blood of infected persons. Additional studies are needed to investigate possible clinical implications.

Download full-text


Available from: Daniele Focosi, Aug 13, 2015
  • Source
    • "A dietary origin for GyV5 and GyV6 DNA in human feces should therefore be considered (Chu et al., 2012; Phan et al., 2012). The lack of human antibodies to CAV argues against human infection with that common chicken virus (Chu et al., 2012) but the reports of HGyV/AGV2 DNA on human skin and in human blood raises the possibility that human infections may also occur (Biagini et al., 2013; Maggi et al., 2012; Sauvage et al., 2011). Testing for human antibodies to all gyroviruses and confirming human infections should clarify whether dietary or occupational exposure to infected chicken can results in human infection. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Gyrovirus genus consists of the immunosuppressive Chicken Anemia Virus (CAV) prototype and since 2011 three other viral species found in sera/tissues of chickens, human feces, and on human skin. Here the genomes of two other gyrovirus species were characterized in diarrhea samples from Tunisian children whose main ORFs shared amino acid identity of 46-59% with those of the previously characterized gyroviruses and were provisionally named GyV5 and GyV6. All currently known gyroviruses grouped into two clades with distinct genomic features including replacement of the VP2 overlapping Apoptin gene with a distinct ORF of unknown function. Previous reports of gyrovirus DNA in human blood and on human skins warrant studies of possible human tropisms for these newly characterized gyroviruses.
    Virology 11/2013; 446(1-2):346-8. DOI:10.1016/j.virol.2013.08.020 · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sequence-independent amplification of clinical specimens can lead to the identification of novel pathogens. To identify novel viruses in human stool specimens from patients with diarrhea and to investigate the ecology and clinical significance of such viruses. Nucleic acid extracted from stool specimens from patients with diarrhea with no known etiology were subjected to random PCR amplification and Roche/454 pyrosequencing. Novel viruses identified were genetically and epidemiologically characterized. Four gyroviruses, chicken anemia virus (CAV), human gyrovirus (HGV)/avian gyrovirus 2 (AGV2), gyrovirus 3 (GyV3) and a novel gyrovirus (tentatively designated as gyrovirus 4 (GyV4)) were identified in human stool specimens. GyV4, as well as CAV and AGV2/HGV were also detected in chicken skin and meat used for human consumption. A novel gyrovirus (GyV4) was identified in human stool and in chicken meat sold for human consumption. This virus was phylogenetically distinct from previously reported gyroviruses in chicken and humans (chicken anemia virus, human gyrovirus, avian gyrovirus 2 and recently reported gyrovirus 3). The epidemiology and pathogenesis of this virus in humans and in chicken needs to be further investigated.
    Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 07/2012; 55(3):209-13. DOI:10.1016/j.jcv.2012.07.001 · 3.47 Impact Factor
  • Source
    Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 03/2013; 57(2). DOI:10.1016/j.jcv.2013.02.015 · 3.47 Impact Factor
Show more